Lexicon Pharmaceuticals said on Friday that Danish drugmaker Novo Nordisk has entered into a licensing deal with the company ...

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...

Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) ...

Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.

Strongrevenueperformance,includingapproximately$1.9millionmilestoneandlicenserevenuerecognizedin2024Up to $7.5 million in grants awarded from ...

Privo Technologies Inc., a pioneering biopharmaceutical company known for its innovative approach to drug delivery and cancer ...